Virtual pain coaching shows promise for breast cancer patients in rural clinics
NCT ID NCT04175639
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a mobile health program to help breast cancer patients in medically underserved areas manage pain and disability. 180 women with breast cancer and persistent pain took part in four video-conferencing sessions over eight weeks, learning coping skills from a remote therapist. The goal was to see if this approach could reduce pain, fatigue, and distress better than a basic health education program.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Mobile Health Pain Coping Skills Training (mPCST) - a behavioral intervention delivered via video-conferencing
- What this could lead to
- If it works, this could provide a non-drug way to manage cancer pain and improve daily function for patients who lack easy access to care.
- What could go wrong
- This is a completed study with 180 participants, so results are available but may not apply to all breast cancer patients. The intervention requires time and commitment, and benefits may vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
180 people
The number who actually took part.
- Started
-
Oct 2021
- Finished
-
Dec 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 99 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. women with a diagnosis of any breast cancer within the last three years 2. being \>18 years old 3. having a life expectancy of \>12 months 4. report experiencing pain on at least 10 days in the last month and rate their pain in the past week as a 4 or greater on a 0-10 scale. The combination of these items assess patients level of persistent pain (in the last month) and pain severity with an accurate recall period (i.e., last week; \>4). Exclusion Criteria: 1. cognitive impairment as indicated by a baseline Folstein Mini-Mental Status Examination of \<2588 2. brain metastases 3. presence of a severe psychiatric condition or a psychiatric condition (e.g., suicidal intent) that would contraindicate safe participation in the study as indicated by the medical chart, treating oncologist, or medical/study staff interactions, or 4) current or past (\<6 months) engagement in PCST for cancer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Duke University Medical Center
Durham, North Carolina, 27705, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a faster radiation course match the standard one after breast reconstruction?
- Can High-Risk breast cancer patients skip an extra radiation boost?
- Radioactive probe lights up CD73 on breast tumors in PET scans
- Can time with horses help cancer patients feel better?
- Can an oral drug replace injections for advanced breast cancer?
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?